Overview
Dr. Frederick P. Smith is a medical oncologist specializing in breast cancer at Sibley Memorial Hospital and an instructor at Johns Hopkins School of Medicine and Georgetown University School of Medicine. He has a private practice in Washington, D.C. He is affiliated with Sibley Memorial Hospital and Suburban Hospital. Dr. Smith earned his medical degree from Saint Louis University School of Medicine. He completed a residency in internal medicine at Georgetown University Hospital, followed by a fellowship in oncology. Dr. Smith was named a 2012 Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas by Castle Connolly, as well as a Top MD by Consumers’ Checkbook Magazine. Prior to joining Johns Hopkins, Dr. Smith was the director of extramural oncology research at Georgetown University. In this position, he contributed over 50 articles to peer-reviewed medical journals. Dr. Smith is an integral advocate in the community for promoting access to clinical research. He has also contributed to clinical trials.
Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Ovarian Carcinosarcoma, and Virilizing Ovarian Tumor.
His clinical research consists of co-authoring 3 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Suite 1640, Chevy Chase, MD 20815
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Skip Viragh Outpatient Cancer Center
Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Carducci is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Orchiectomy.
Inova Health Care Services
Jeanny Aragon-Ching is an Oncologist and a Hematologist in Alexandria, Virginia. Dr. Aragon-Ching is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Prostate Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy. Dr. Aragon-Ching is currently accepting new patients.
Mario Eisenberger is an Oncologist in Baltimore, Maryland. Dr. Eisenberger is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, Familial Prostate Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Smith isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Breast CancerDr. Smith isDistinguished. Learn about Breast Cancer.
- Lung AdenocarcinomaDr. Smith isDistinguished. Learn about Lung Adenocarcinoma.
- Ovarian CarcinosarcomaDr. Smith isDistinguished. Learn about Ovarian Carcinosarcoma.
- Paget Disease of the BreastDr. Smith isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Smith isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- AngiosarcomaDr. Smith isAdvanced. Learn about Angiosarcoma.
- EGFR Positive Lung CancerDr. Smith isAdvanced. Learn about EGFR Positive Lung Cancer.
- Familial Pancreatic CancerDr. Smith isAdvanced. Learn about Familial Pancreatic Cancer.
- Gastric LymphomaDr. Smith isAdvanced. Learn about Gastric Lymphoma.
- Inflammatory Breast CancerDr. Smith isAdvanced. Learn about Inflammatory Breast Cancer.
- Large-Cell Lung CarcinomaDr. Smith isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Smith isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Smith isExperienced. Learn about Agranulocytosis.
- Ampullary CancerDr. Smith isExperienced. Learn about Ampullary Cancer.
- B-Cell LymphomaDr. Smith isExperienced. Learn about B-Cell Lymphoma.
- Bladder CancerDr. Smith isExperienced. Learn about Bladder Cancer.
- Bone TumorDr. Smith isExperienced. Learn about Bone Tumor.